Human papillomavirus/p16 positive head and neck cancer in India: Prevalence, clinical impact, and influence of tobacco use
Vedang Murthy(Homi Bhabha National Institute), J. P. Agrawal(Tata Memorial Hospital), Tejpal Gupta(Tata Memorial Hospital), Tanuja Teni(Advanced Centre for Treatment, Research and Education in Cancer), Monali Swain(Tata Memorial Hospital), Shashi Singh Pawar(Advanced Centre for Treatment, Research and Education in Cancer), Asawari Patil(Tata Memorial Hospital), Prajakta Kalkar(Advanced Centre for Treatment, Research and Education in Cancer), S. Ghosh Laskar(Tata Memorial Hospital), Sujata Ghonge(Advanced Centre for Treatment, Research and Education in Cancer), A. Budrukkar(Tata Memorial Hospital), Ajit Chande(Advanced Centre for Treatment, Research and Education in Cancer)
Cited by 56
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340